Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Chimiothérapie
Extract
A multicenter randomized study to compare the combination trastuzumab and capecitabine, with or without pertuzumab on progression free survival, as 2nd-line treatment in patients with HER2-positive metastatic breast cancer that has progressed after previous treatment with trastuzumab.
Scientific Abstract
en cours d'intégration;